Health Insurance

UnitedHealthcare has delayed from April 1, 2021, until Jan. 1, 2022, its requirement that certain in-network laboratories report their unique laboratory-specific codes along with other information for the overwhelming majority of freestanding and outpatient laboratory testing services.
Enrollment in private health insurance plans remained concentrated among a small number of issuers in 2017 and 2018, according to a report released by the Government Accountability Office.
The U.S. Supreme Court Nov. 10 will hear oral argument in California v. Texas, the latest challenge to the Affordable Care Act. 
Some health care needs are predictable but some are not. We can plan around giving birth, having a heart bypass, or scheduling a colonoscopy. But there are also surprises, such as injuries from accidents, or a cancer that appears with no family history … or COVID-19.
We’ve been discussing for months how hospitals and health systems are contending with the worst financial crisis in their history as they continue to serve on the front lines of the fight against COVID-19.
The Departments of Health and Human Services, Treasury and Labor released its transparency-in-coverage final rule imposing new requirements upon group health plans and issuers of health insurance coverage in the individual and group markets.
As the House Energy and Commerce Committee investigates health insurance company performance during the COVID-19 pandemic, AHA urges the committee to ensure insurance premiums support access to care.
The average premium for a benchmark plan at HealthCare.gov will decline 2% in 2021 to $379, the Centers for Medicare & Medicaid Services announced.
Walmart’s strategy is simple: Find ways to help customers save money and live better. With its ever-expanding reach into health care, however, Walmart has entered a new phase by becoming a licensed health insurance broker in an effort to forge stronger bonds with millions of consumers.
The American Medical Association’s annual review of U.S. health insurance markets indicates an erosion of competition and choice for many patients, particularly in markets where it is most scarce.